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INTRODUCTION
Soft-tissue sarcomas are mesenchymal tumors that 
occur most commonly in the extremities, but with a cu-
mulative incidence of less than 1% per year.1 Although 
most extremity and truncal soft-tissue sarcomas are lo-
cated deep within myofascial compartments, superficial 
soft-tissue sarcomas (S-STS) are relatively less common 
and differ from deep STS in several important ways.2–7 S-
STS are frequently smaller3,4 than deep tumors, and as a 
result are associated with lower rates of distant metastasis 
and higher rates of disease-free survival (DFS).4,8 Resec-
tion of S-STS rarely involves critical structures, such as 
major nerves and arteries, which are typically involved 
with deeper tumors. However, due to their small size and 
superficial location, these lesions may be not be recog-
nized as malignant on initial presentation and are fre-
quently treated by marginal or intralesional resection 
before referral to a dedicated sarcoma center, a scenario 
often referred to as an “unplanned excision.”9,10 In these 
cases, resection margins are frequently positive necessi-
tating further treatment.
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Objective: Soft-tissue sarcomas are most frequently located deep within myofascial 
compartments. Superficial soft-tissue sarcomas (S-STS) are relatively less common 
and may be managed differently than deep sarcomas because generous resection 
margins are often possible without sacrificing critical structures. We sought to in-
vestigate the frequency and types of soft-tissue reconstructive procedures that are 
required following excision of S-STS.
Methods: We reviewed 457 consecutively treated patients with S-STS with a minimum 
2-year follow-up from our prospectively maintained database between 1989 and 2009.
Results: Mean follow-up was 10.5 years (range, 2–23). Four hundred twenty-one tu-
mors (91%) were excised with negative margins, 38 (8.3%) had microscopically posi-
tive margins, and three (0.7%) had grossly positive margins. One patient required an 
amputation. In 271 (58%) patients, the wounds were closed primarily. In compari-
son, 93 patients (20%) required a rotation flap, 70 (15%) required a split-thickness 
skin graft, and 23 (5%) underwent a free tissue transfer (ie, advanced reconstruc-
tive procedure). The overall complication rate was 12%, although 43% of patients 
undergoing free tissue transfer developed complications (P = 0.04). An unplanned 
excision before referral to our center was a risk factor for local recurrence (P = 0.03) 
when residual tumor was recovered in the reexcision specimen pathologically.
Conclusions: Although concern about the morbidity associated with a free tissue 
transfer (ie, advanced reconstructive procedure) may potentially limit the adequa-
cy of resection in some patients with S-STS, the results of this study showed that 
the majority of patients had complete excisions with negative margins and pri-
mary closure. Obtaining a negative margin when excising a known or suspected 
S-STS rarely requires an advanced reconstructive procedure and almost never 
results in loss of limb. (Plast Reconstr Surg Glob Open 2017;5:e1553; doi: 10.1097/
GOX.0000000000001553; Published online 13 November 2017.)
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Using the largest series of consecutively treated pa-
tients with S-STS to date, this study aims to investigate the 
frequency and types of soft-tissue reconstructive proce-
dures that are required following definitive resection of 
S-STS. In this study, we also investigate relevant oncologic 
outcomes.
METHODS AND MATERIALS
Patients and Treatment
Between January 1986 and December 2009, 1,295 con-
secutive patients with soft-tissue sarcoma of the trunk and 
extremities were enrolled in the prospectively maintained 
database. Among these patients, 457 (35%) underwent 
surgical resection for a histologically proven S-STS of the 
extremities or trunk. We defined S-STS as a malignant 
mesenchymal neoplasm located exclusively superficial to 
the fascia of the underlying muscular compartment. This 
assessment was based on magnetic resonance imaging as 
well as clinical assessment at the time of surgery. For in-
stance, a patient assessed as having an S-STS preoperatively 
but found to have fixation to or transgression through the 
underlying fascia was not classified as having an S-STS. Pa-
tients with Kaposi’s sarcoma and atypical fibroxanthoma 
were excluded. Malignant ulceration was defined as visible 
ulceration or fungation of the tumor through the skin.
The surgical plan for each patient was made with pri-
ority given to performing a wide excision of the tumor 
(or tumor bed in the case of patients undergoing revision 
surgery). For patients in whom free tissue transfer was 
expected (ie, advanced reconstructive procedure requir-
ing a multidisciplinary surgical team), the plastic surgery 
team was available to perform immediate reconstruction. 
For patients in whom reconstruction was expected to be 
performed by the orthopedic oncologist (eg, basic rota-
tion flaps, skin grafts), the plastic surgery team was not 
directly involved in the case. In all patients, the soft-tissue 
reconstruction was performed during the same operation 
as the resection.
Data Collection and Statistical Analysis
A retrospective patient review of a prospectively col-
lected database was performed following Research Ethics 
Board approval. Data collected included patient age and 
gender, tumor size and location, tumor grade, treatment 
before referral to the sarcoma center, local recurrence fol-
lowing prior treatment elsewhere, utilization of adjuvant 
therapy, margins at definitive surgical resection (ie, closest 
margin, closest radial margin), and disease status at diag-
nosis and final follow-up. The deep margin for all patients 
in this study was fascia. The goal for margin of resection 
was 2 cm, though margins were considered negative if they 
demonstrated no signs of microscopically positive margins 
at the time of resection. The type of soft-tissue reconstruc-
tive procedure required after definitive resection was cat-
egorized as primary wound closure, skin graft alone, local 
rotation flap +/- skin graft, and free tissue transfer (ie, 
advanced reconstructive procedure) +/- skin graft. For 
patients who had undergone prior “unplanned excision” 
before referral, we examined whether they had positive re-
section margins and whether there was residual tumor re-
covered in the reexcision specimen pathologically. Once 
patients had been seen by a specialty sarcoma center, we 
examined whether surgical margins were positive or nega-
tive and noted local recurrence, overall survival (OS), and 
overall DFS. Finally, we determined which reconstructive 
surgery, if any, patients required after completing their de-
finitive surgical excision.
Patient, disease, and treatment-related variables for 
patients with different types of soft-tissue reconstruction 
were compared using Fisher’s exact test or the chi-square 
test. Survival curves were calculated using the Kaplan-
Meier method and survival differences were compared by 
the log-rank test. To investigate for differences between 
reconstructive type and disease variables (eg, tumor size), 
the log rank test was applied. Logistic regression models 
were also used to evaluate the effect of patient and tumor 
characteristics on local recurrence and OS outcomes in 
the form of hazard ratios; these ratios are factors that indi-
cate the multiplicative factor of comparative risk between 
2 groups.
RESULTS
Patients and Disease Characteristics
A total of 457 patients were identified in our database 
that had STS-E with a mean follow-up of 10.5 years (range, 
2–23 years). Baseline patient and tumor features are pre-
sented in Table 1. Mean patient age was 55 years (range, 
18–97 years). Three hundred forty-six patients (76%) 
had undergone an unplanned excision before referral to 
Table 1. Baseline Patient and Tumor Characteristics
Patient Characteristics Mean (Range)/n (%) P
Age at diagnosis (y) 55 (18–97)  
Sex, N (%)   
  Male 251 (55) 0.554
  Female 206 (45) 0.446
Unplanned excision before referral 346 (76)  
  Subset with prior positive margin 281 (81) 0.867
  Subset with prior close but negative 
margin
65 (19) 0.133
  Subset with residual tumor found on 
reexcision
151 (44)  
Tumor maximum diameter (cm) 4.6 (0.5–23.0)  
Tumor location   
  LE 292 (64) 0.586
  UE 165 (36) 0.306
Histological diagnosis and subtype   
  Undifferentiated pleomorphic 
sarcoma
178 (39)  
  Leiomyosarcoma 91 (20)  
  Myxoid/round cell liposarcoma 36 (8)  
  Fibrosarcoma 29 (6)  
  Malignant peripheral nerve sheath 
tumor
22 (4)  
  Other 101 (22)  
Tumor grade   
  Grade I 87 (19) 0.195
  Grade II 142 (31) 0.31
  Grade III 224 (49) 0.495
  Unknown 4 (0.8)  
Malignant ulceration 46 (10)  
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our institution; of these, resection margins were positive 
in 281 patients (81%). Two hundred ninety-two tumors 
(64%) were located on the lower extremity and 165 tu-
mors (36%) were located on the upper extremity. Mean 
tumor size was 4.6 cm (range, 0.5–23 cm). The most com-
mon histologies were undifferentiated pleomorphic sar-
coma (n = 178; 39%), leiomyosarcoma (n = 91; 20%), and 
myxoid liposarcoma (n = 36; 8%; Table 1). There were 87 
grade I tumors (19%), 142 grade II tumors (31%), and 
224 grade III tumors (49%). In 4 tumors, a grade was not 
assigned. Malignant ulceration was present at the time of 
surgery in 46 tumors (10%). There were no patients with 
known metastatic disease at the time of surgery. There 
were no statistically significant differences in patient and 
tumor characteristics.
Treatment Modalities and Reconstructive Techniques
Definitive resection margins were negative in 421 pa-
tients (92%) and positive in 36 patients (8%; Table 2). 
The majority of patients (n = 346; 76%) underwent wide 
reexcision at our center following a prior unplanned re-
section performed elsewhere. One hundred ninety-seven 
patients (43%) were treated with adjuvant or neoadjuvant 
radiation therapy after referral to our institution, whereas 
only 6 patients (1%) received adjuvant or neoadjuvant 
chemotherapy. Two hundred seventy-one patients (58%) 
underwent wide resection and primary wound closure. 
Ninety-three patients (20%) underwent wide resection 
and closure with a rotation flap and split-thickness skin 
graft (STSG). Seventy patients (15%) underwent wide re-
section and coverage with an STSG alone. Twenty-three 
patients (5%) required a free tissue transfer for coverage 
of the resected site.
Complications and Outcomes
Postoperative complications by reconstruction group 
are listed in Table 3. Fifty-six patients (12%) had a com-
plication directly related to surgery, and 19 (34%) of 
them required reoperation. Patients undergoing free tis-
sue transfer were the most likely to have a complication 
(10/23; 43%; P = 0.04). In comparison, complications oc-
curred in 16 of 93 patients (17%) treated with a rotation 
flap and 10 of 70 (14%) who had an STSG alone. Only 20 
of 271 patients (8%) treated with primary wound closure 
developed a complication. However, this group included 
2 patients with significant complications: One patient un-
derwent resection of a posterior leg S-STS and, following 
primary closure, developed compartment syndrome. She 
was treated with fasciotomies and delayed wound closure. 
Another patient had microscopically positive margins af-
ter resection of a distal leg S-STS and developed a wound 
infection. She elected to have a transtibial amputation 
rather than another attempt at limb-preserving resection 
(which likely would have required a free tissue transfer) or 
radiation therapy.
Mean OS was 71 months with a mean DFS of 65 
months (Table 2). Five-year local recurrence-free survival 
rates were greater than 90% for tumors of every grade 
(Fig. 1A; P = 0.058). Five-year metastasis-free survival was 
96.1%, 89.3%, and 78.5% for grades 1, 2, and 3, respec-
tively (Fig. 1B; P < 0.001).
Patients who underwent an unplanned excision before 
referral had an increased risk of local recurrence but only 
when residual tumor was recovered pathologically from 
reexcision specimen (P = 0.009; hazard ratio, 3.1). This 
Table 2. Baseline Treatment Characteristics
Patient Characteristics Mean (Range)/n (%) P
Resection type   
  Primary wide resection 111 (24)  
  Wide reexcision of the tumor bed 
following prior unplanned resection
346 (76)  
Overall margin status   
  Negative 421 (92) 0.924
  Positive 36 (8) 0.076
Type of soft-tissue reconstruction   
  Primary closure 271 (58) 0.598
  STSG 70 (15) 0.144
  Rotation flap 93 (20) 0.215
  Free flap 23 (5) 0.053
Radiation therapy   
  No radiation therapy 260 (57) 0.571
  Preoperative radiation 127 (28) 0.284
  Postoperative radiation 60 (13) 0.131
  Preoperative radiation with postop-
erative boost
10 (2) 0.014
Chemotherapy 6 (1) 0.012
Follow-up, survival, and events   
  Follow-up (y) 10.5 (2–23)  
  OS time (mo) 71 (4–247)  
DFS (mo) 65 (1–187)  
% 5-Year metastasis (grade 1) 96.10  
Free survival by tumor grade (%)   
  Grade 2 89.30  
  Grade 3 78.50  
% 5-Year local recurrence (grade 1) 99.20  
Free survival by tumor grade (%)   
  Grade 2 92.80  
  Grade 3 91.00  
Disease following reexcision   
  Positive for disease 151 (44)  
  No disease 196 (56)  
Table 3. Postoperative Complications Stratified by 
Reconstruction Group
Soft Tissue  
Reconstruction Group
Complication  
Type
Total 
Number 
(%)
Number 
Reoperated 
(%)
Primary wound closure 
(n = 271)  20 (7) 8 (3)
 Wound infection 11 (4.1) 5 (1.8)
 Wound dehiscence 5 (1.8) 1 (0.4)
 Wound seroma 2 (0.7) 0
 Vascular 2 (0.7) 2 (0.7)
STSG (n = 70)  10 (14) 3 (4)
 Infection 6 (8.6) 2 (2.9)
 Vascular 1 (1.4) 1 (1.4)
 Other 3 (4.3) 0
Rotation flap +/- STSG 
(n = 93)
 16 (17) 4 (4.3)
 Infection 12 (13) 4 (4.3)
 Dehiscence 4 (4) 0
Free tissue transfer +/- 
STSG (n = 23)
 10 (43) 4 (17)
 Infection 7 (30) 3 (13)
 Flap failure 1 (4) 1 (4)
 Dehiscence 1 (4) 0
 Seroma 1 (4) 0
Total All types 56 (12) 19 (4)
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event occurred in 151 of 346 patients (44%) and was asso-
ciated with a hazard ratio for local recurrence of 5.9 when 
compared with those patients in whom tumor was not re-
covered upon reexcision. These patients were not more 
likely to require an advanced reconstructive procedure or 
to have a complication.
DISCUSSION
S-STS are underrepresented in the literature despite 
having significantly different biology and clinical out-
comes from their deep equivalents. An oft-cited reason for 
inadequate margins obtained in the treatment of S-STS of 
the extremities is the desire to avoid the need for soft-tis-
sue reconstructive procedures.10 However, although wide 
excision of S-STS may be viewed as undesirable from a 
reconstructive and cosmetic perspective, multiple studies 
have shown that obtaining an adequate resection margin 
is a critical for local control and an independent predictor 
of disease-free and metastasis-free survival.4–6,11 No data ex-
ist to describe what types of reconstructive procedures are 
typically required or their frequency following excision of 
S-STS of the extremities. Therefore, we performed a dedi-
cated analysis of the largest series of consecutively treated 
patients with S-STS of the extremities to determine the 
utilization and complications associated with soft-tissue 
reconstructive procedures.
We demonstrate that limb preservation can almost al-
ways be accomplished when treating patients with S-STS. 
Only 1 patient in this series of 457 patients required an 
amputation, despite an overall complication rate of 12%. 
This paucity of amputations underlies an important dif-
ference between superficial and deep STS. Wound com-
plications including infection and dehiscence following 
treatment of patients for deep STS often result in compro-
mise of skeletal, neurologic, or vascular structures that are 
critical for limb preservation. In comparison, patients with 
S-STS may often require reoperation but rarely result in 
loss of the limb following similar complications.
At our institution, orthopedic oncologists perform 
STSGs and many rotation flaps. A separate plastic micro-
surgical reconstructive team performs more complex rota-
tion flaps and all free tissue transfers. In the present study, 
only 5% of patients required a free tissue transfer. The 
majority of patients (58%) required only primary wound 
closure, and another 35% required closures that could be 
performed by an orthopedic oncologist. This was not due 
to less aggressive resection techniques, as the surgical re-
section margins were negative in 92% of the patients in 
this series.
In general, the complication rate increased with the 
complexity of the reconstructive procedure required. 
Free tissue transfer was associated with the highest rate of 
complications (43%) and reoperation (13%), but there 
were no failures of limb salvage in this treatment group. 
There was free anterolateral thigh flap to the dorsal fore-
arm that failed due to thrombosis. This flap was partially 
debrided and the resulting wound healed by secondary 
intention. Although the lowest rate of complications was, 
not surprisingly, associated with primary wound closure, 
this group of patients also encountered the 2 most severe 
complications—1 patient required emergent fasciotomies 
for compartment syndrome and another patient with 
contaminated margins developed a severe infection that 
ultimately required an amputation. Two patients initially 
treated with primary closure required conversion to skin 
grafts after wound dehiscence and open wound manage-
ment. These were the only 2 patients who required con-
version from one reconstructive type to another.
Recently, there has been increasing attention focused on 
the effect of an unplanned sarcoma excision before referral 
for definitive treatment.10,12–15 Unplanned excisions are of-
Fig. 1.  Kaplan-Meier curves illustrating 5-year local recurrence-free survival (a) and 5-year metastasis-free survival according to grade 
(B). a, With respect to local recurrence-free survival, patients with grades 1, 2, and 3 tumors had a survival rate of 99.2%, 92.8%, and 91%, 
respectively (P = 0.058). B, With respect to metastasis-free survival, patients with grades 1, 2, and 3 tumors had a survival rate of 96.1%, 
89.3%, and 78.5%, respectively (P < 0.001).
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ten the result of an understandable failure to identify a su-
perficial mass as a sarcoma. The majority of patients in this 
study (n = 346; 76%) were referred to our center second-
ary to unplanned surgical excisions performed elsewhere, 
and most of them also had positive surgical margins (281; 
81%), whereas a smaller group (65; 19%) had negative but 
very close (eg, 1–2 mm) margins. In this series, having had 
a prior unplanned excision did not predict the need for an 
advanced reconstructive procedure. It also did not gener-
ally affect oncologic outcomes although those patients in 
whom tumor was identified pathologically in the reexcision 
specimen were at higher risk to develop a local recurrence 
(P = 0.005). We would consider offering adjuvant radiation 
therapy to such patients depending on the status of their fi-
nal resection margins. However, the use of radiation thera-
py may significantly impact reconstructive decision making 
and is well known to affect wound healing.16,17
The demographic characteristics of patients with S-STS 
in this series have several differences compared with other 
reports of extremity S-STS. In the present series, 68% of 
tumors were smaller than 5 cm in maximum diameter. Al-
though the relative prevalence of small (ie, less than 5 cm) 
tumors in this series may have influenced the low rate of 
advanced reconstructive procedures, it should be noted 
that other series of S-STS had an even greater proportion 
of small tumors. Cany et al.5 reported that 92% of S-STS 
in their series of 105 patients were smaller than 5 cm, and 
Salas et al.7 reported that 76% of S-STS in their series of 
367 patients were under 5 cm.
Using the largest reported series of consecutively treat-
ed patients with S-STS, we demonstrate that completely 
resected S-STS rarely require advanced reconstructive pro-
cedures. The importance of proper surgical planning and 
management for patients with S-STS, with an emphasis on 
wide negative margin excision, cannot be understated. 
Concerns about the need for using free soft-tissue trans-
fers (ie, advanced reconstructive procedures) should not 
be a factor in limiting surgical margins or otherwise com-
promising a complete excision. Although advanced recon-
structive techniques, when required, carry a high rate of 
complications, this does not compromise the likelihood of 
limb salvage. The biggest dilemma in dealing with S-STS 
remains the high proportion of patients who continue to 
be treated initially in the community as benign lesions and 
are only referred to specialty sarcoma centers following in-
complete resections. This will only be improved through 
development and dissemination of management guide-
lines to facilitate early referral of a greater proportion of 
patients with superficial masses who actually have S-STS.18
William C. Eward
Duke University Medical Center
Box 3312 DUMC
Durham, NC 27710
E-mail: w.eward@alumni.duke.edu
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